Form 4 for OPRX OptimizeRx Corp
Accepted 2021-08-10 00:00:00 ET · period of report 2021-08-09 · accession 0001213900-21-041400 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-08-10 | 2021-08-09+ | OPRX | BAKER DOUGLAS P | CFO | S - Sale+OE | $64.34 | -12.0K | 64.8K | -16% | -$772.1K |
| D | 2021-08-10 | 2021-08-09 | OPRX | BAKER DOUGLAS P | CFO | M - OptEx | $7.51 | +10.0K | 74.8K | +15% | +$75.1K |
| D | 2021-08-10 | 2021-08-09 | OPRX | BAKER DOUGLAS P | CFO | M - OptEx | $7.51 | -10.0K | 54.7K | -15% | -$75.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock (pursuant to 10B5-1 plan) | 2021-08-10 | S | D | 2,000 | $64.50 | 72,796 | D | — | — | (F2) These shares sold pursuant to a plan of disposition adopted on May 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended |
| 2 | Common | Common Stock | 2021-08-09 | M | A | 10,000 | $7.51 | 74,796 | D | — | — | |
| 3 | Common | Common Stock (pursuant to 10B5-1 plan) | 2021-08-09 | S | D | 10,000 | $64.31 | 64,796 | D | — | — | (F1) These shares sold pursuant to a plan of disposition adopted on March 24, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. |
| 4 | Derivative | Stock Option | 2021-08-09 | M | D | 10,000 | $7.51 | 54,699 | D | $7.51 · 2020-06-30 to 2022-03-31 | 10,000 Common Stock |